Hypnosis for Smoking Relapse Prevention
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 11/2/2017 |
| Start Date: | June 2007 |
| End Date: | June 2011 |
A majority of smokers who quit return to smoking within three months of their quit date. This
study is a randomized trial to investigate the effectiveness of hypnosis versus behavioural
counseling to promote maintenance of abstinence or relapse prevention in quitting smokers.
The hypothesis is that hypnosis will be at least as effective as behavioral counseling in
preventing relapse to smoking in smokers who are able to quit for at least three days.
study is a randomized trial to investigate the effectiveness of hypnosis versus behavioural
counseling to promote maintenance of abstinence or relapse prevention in quitting smokers.
The hypothesis is that hypnosis will be at least as effective as behavioral counseling in
preventing relapse to smoking in smokers who are able to quit for at least three days.
We will enroll 520 current smokers in the study. All subjects will participate in an initial
smoking cessation intervention involving brief counseling and nicotine replacement therapy.
Participants who are able to achieve at least 3 consecutive days of abstinence will be
randomized to one of two relapse prevention interventions. The participants in Study Arm 1
will receive a hypnosis intervention designed to facilitate relapse prevention. Participants
in Study Arm 2 will participate in empirically-supported behavior relapse prevention
counseling, utilizing the National Cancer Institute's Forever Free materials. Both
interventions will be conducted in two 60-minute individual sessions scheduled one week apart
in addition to counseling phone calls on their quit date and after relapse prevention
treatment.
Outcomes for the two study arms will be compared by assessing biochemically-validated
point-prevalence smoking status at 9 weeks(end of treatment), 26 weeks and 52 weeks. Hypnosis
for relapse prevention is designed to sustain the ex-smokers commitment to remain abstinent,
to provide a review of behavioral skills to resist the temptations to smoke, and to encourage
attempts to quit again if relapse occurs.
smoking cessation intervention involving brief counseling and nicotine replacement therapy.
Participants who are able to achieve at least 3 consecutive days of abstinence will be
randomized to one of two relapse prevention interventions. The participants in Study Arm 1
will receive a hypnosis intervention designed to facilitate relapse prevention. Participants
in Study Arm 2 will participate in empirically-supported behavior relapse prevention
counseling, utilizing the National Cancer Institute's Forever Free materials. Both
interventions will be conducted in two 60-minute individual sessions scheduled one week apart
in addition to counseling phone calls on their quit date and after relapse prevention
treatment.
Outcomes for the two study arms will be compared by assessing biochemically-validated
point-prevalence smoking status at 9 weeks(end of treatment), 26 weeks and 52 weeks. Hypnosis
for relapse prevention is designed to sustain the ex-smokers commitment to remain abstinent,
to provide a review of behavioral skills to resist the temptations to smoke, and to encourage
attempts to quit again if relapse occurs.
Inclusion Criteria:
- currently smoking at least 5/cigarettes per day during the past week
- willingness to participate and give informed consent
- aged 18 and above
Exclusion Criteria:
- contraindications to nicotine replacement
- pregnancy, lactation
- unstable psychiatric disorders
- current (last 3 months)substance use disorder
- terminal illness
- current use of smoking cessation medication
We found this trial at
1
site
4150 Clement Street
San Francisco, California 94121
San Francisco, California 94121
Click here to add this to my saved trials
